Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
11.59
+1.43 (14.07%)
At close: Sep 26, 2025, 4:00 PM EDT
11.70
+0.11 (0.94%)
After-hours: Sep 26, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M